IRIS Accounts Production v25.1.4.42 12216504 director 1.10.23 30.9.24 30.9.24 0 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122165042023-09-30122165042024-09-30122165042023-10-012024-09-30122165042022-09-30122165042022-10-012023-09-30122165042023-09-3012216504ns15:EnglandWales2023-10-012024-09-3012216504ns14:PoundSterling2023-10-012024-09-3012216504ns10:Director12023-10-012024-09-3012216504ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3012216504ns10:Micro-entities2023-10-012024-09-3012216504ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3012216504ns10:FullAccounts2023-10-012024-09-3012216504ns5:CurrentFinancialInstruments2024-09-3012216504ns5:CurrentFinancialInstruments2023-09-3012216504ns5:Non-currentFinancialInstruments2024-09-3012216504ns5:Non-currentFinancialInstruments2023-09-3012216504ns10:RegisteredOffice2023-10-012024-09-30122165041ns10:Director12023-09-30122165041ns10:Director12022-09-30122165041ns10:Director12023-10-012024-09-30122165041ns10:Director12022-10-012023-09-30122165041ns10:Director12024-09-30122165041ns10:Director12023-09-30
REGISTERED NUMBER: 12216504 (England and Wales)















SHROPSHIRE ANAESTHESIA LTD.

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






SHROPSHIRE ANAESTHESIA LTD. (REGISTERED NUMBER: 12216504)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Statement of Financial Position 1


SHROPSHIRE ANAESTHESIA LTD. (REGISTERED NUMBER: 12216504)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

2024 2023
£    £    £    £   
FIXED ASSETS 38,885 45,458

CURRENT ASSETS 22,305 48,261

CREDITORS
Amounts falling due within one year (26,366 ) (29,441 )
NET CURRENT (LIABILITIES)/ASSETS (4,061 ) 18,820
TOTAL ASSETS LESS CURRENT
LIABILITIES

34,824

64,278

CREDITORS
Amounts falling due after more than one
year

(12,936

)

(19,574

)
NET ASSETS 21,888 44,704

CAPITAL AND RESERVES 21,888 44,704

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Shropshire Anaesthesia Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12216504

Registered office: Redcote
Lower Wood
Church Stretton
Shropshire
SY6 6LF

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2023 - NIL).

SHROPSHIRE ANAESTHESIA LTD. (REGISTERED NUMBER: 12216504)

STATEMENT OF FINANCIAL POSITION - continued
30 SEPTEMBER 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2024 and 30 September 2023:

2024 2023
£    £   
Dr S Bowdler
Balance outstanding at start of year 27,784 25,921
Amounts advanced 47,121 82,180
Amounts repaid (76,244 ) (80,317 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,339 ) 27,784



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 27 June 2025 and were signed by:





Dr S Bowdler - Director